These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23494670)

  • 1. The prognostic value of platelet endothelial cell adhesion molecule-1 in non-small-cell lung cancer patients.
    Kuang BH; Wen XZ; Ding Y; Peng RQ; Cai PQ; Zhang MQ; Jiang F; Zhang XS; Zhang X
    Med Oncol; 2013 Jun; 30(2):536. PubMed ID: 23494670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hypoxia-inducible factor prolyl hydroxylase 3 HIFPH3 in human non-small cell lung cancer (NSCLC) and its correlation with prognosis.
    Chu X; Zhu CC; Liu H; Wang JC
    Asian Pac J Cancer Prev; 2014; 15(14):5819-23. PubMed ID: 25081707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances].
    Zhu ZH; Rong TH; Zeng CG; Wu QL; Ma Y; Huang XP; Li BJ; Zhang PY; Zhao JM; Hu W; Zhang SY; Yu H; Ma GW; Zhang LJ; Wen ZS; Fu JH; Long H
    Ai Zheng; 2005 Jul; 24(7):865-9. PubMed ID: 16004817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.
    Mineo TC; Ambrogi V; Baldi A; Rabitti C; Bollero P; Vincenzi B; Tonini G
    J Clin Pathol; 2004 Jun; 57(6):591-7. PubMed ID: 15166262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation Analysis Among the Level of IL-35, Microvessel Density, Lymphatic Vessel Density, and Prognosis in Non-Small Cell Lung Cancer.
    Zhang T; Nie J; Liu X; Han Z; Ding N; Gai K; Liu Y; Chen L; Guo C
    Clin Transl Sci; 2021 Jan; 14(1):389-394. PubMed ID: 33048433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TFIIB-related factor 2 over expression is a prognosis marker for early-stage non-small cell lung cancer correlated with tumor angiogenesis.
    Lu M; Tian H; Yue W; Li L; Li S; Qi L; Hu W; Gao C; Si L
    PLoS One; 2014; 9(2):e88032. PubMed ID: 24523874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Nuclear Heat Shock Factor 1 Contributes to Tumor Angiogenesis and Poor Survival in Patients With Non-Small Cell Lung Cancer.
    Cui J; Tian H; Chen G
    Ann Thorac Surg; 2015 Aug; 100(2):465-72. PubMed ID: 26095102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
    Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
    Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
    Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
    Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry.
    Wu S; Yu L; Cheng Z; Song W; Zhou L; Tao Y
    J Huazhong Univ Sci Technolog Med Sci; 2012 Jun; 32(3):346-352. PubMed ID: 22684556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of microvascular density for response to anlotinib in advanced NSCLC.
    Liu D; Ding G
    Medicine (Baltimore); 2022 Jan; 101(3):e28647. PubMed ID: 35060554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of LAPTM4B is correlated with tumor angiogenesis and poor prognosis in non-small cell lung cancer.
    Tang H; Tian H; Yue W; Li L; Li S; Gao C; Si L; Qi L; Lu M
    Med Oncol; 2014 Jun; 31(6):974. PubMed ID: 24816841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).
    Hötzel J; Melling N; Müller J; Polonski A; Wolters-Eisfeld G; Izbicki JR; Karstens KF; Tachezy M
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2285-2292. PubMed ID: 31372722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of metastasis-associated protein 1 is significantly correlated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
    Li SH; Tian H; Yue WM; Li L; Li WJ; Chen ZT; Hu WS; Zhu YC; Qi L
    Ann Surg Oncol; 2011 Jul; 18(7):2048-56. PubMed ID: 21290196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab.
    Zhao YY; Xue C; Jiang W; Zhao HY; Huang Y; Feenstra K; Resau JH; Qian CN; Zhang L
    J Thorac Oncol; 2012 Jan; 7(1):71-5. PubMed ID: 22011670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.
    Sun JG; Wang Y; Chen ZT; Zhuo WL; Zhu B; Liao RX; Zhang SX
    J Exp Clin Cancer Res; 2009 Feb; 28(1):21. PubMed ID: 19216806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of phosphatase and tensin homolog expression predict favorable prognosis in patients with non-small cell lung cancer.
    Li XB; Yang Y; Zhang HQ; Yue WT; Zhang TM; Lu BH; Li J; Liu Z; Wang QH; Gao Y; Hu AM; Zhang HM; Shi HL; Hu FB; Li BL
    Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2231-9. PubMed ID: 26166648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
    Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
    Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC.
    Luo YQ; Ming Z; Zhao L; Yao LJ; Dong H; Du JP; Wu SZ; Hu W
    IUBMB Life; 2012 May; 64(5):423-31. PubMed ID: 22473740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
    Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
    Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.